v2.3.0.11

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Jun. 30, 2011	Dec. 31, 2010
ASSETS
Cash and cash equivalents	$ 65,082	$ 245,869
Accounts receivable, net	7,641	4,165
Receivable from sale of subsidiary	0	39,231
Inventories, net	69,977	63,282
Prepaid expenses and other current assets	44,988	44,850
Total Current Assets	187,688	397,397
Property and equipment, net	2,690,214	2,824,849
Land use right, net	344,134	347,620
TOTAL ASSETS	3,222,036	3,569,866
LIABILITIES AND EQUITY
Accounts payable	74,798	16,120
Notes payable	61,538	0
Line of credit	74,700	0
Accrued expenses and other payables	126,188	64,110
Due to director	56,929	23,757
Derivative liabilities	168,087	170,551
Total Current Liabilities	562,240	274,538
Commitments and contingencies
Equity
Common stock, $0.001 par value, 100,000,000 shares authorized, 45,070,245 shares issued and outstanding	45,070	45,070
Additional paid-in capital	19,078,722	18,987,707
Subscription receivable	(210,748)	(210,325)
Stock to be issued, 1,323,000 and 900,000 shares, respectively	521,023	520,600
Accumulated other comprehensive income	442,377	426,626
Accumulated deficit	(17,218,388)	(16,576,534)
Total Bio-Bridge Science, Inc. Shareholders' Equity	2,658,056	3,193,144
Noncontrolling Interests	1,740	102,184
Total Equity	2,659,796	3,295,328
TOTAL LIABILITIES AND EQUITY	$ 3,222,036	$ 3,569,866

Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Also includes, carrying amount as of the balance sheet date of other payables not otherwise specified in the taxonomy.

BIO BRIDGE SCIENCE INC 10-Q/A